Literature DB >> 4041363

Cytotoxicity of etretinate and vindesine.

J M Gaukroger, L Wilson, R MacKie.   

Abstract

The effects of an aromatic retinoid, etretinate and a vinca alkaloid, vindesine were investigated by culture of malignant melanoma cells in vitro with these two agents; either separately or in combination. Etretinate inhibited growth of a murine melanoma but only minimal effects were recorded with two human melanomas. Vindesine however, was inhibitory for all of the cell lines and this effect was enhanced in the presence of the retinoid. Entry of 3H labelled vindesine or etretinate into drug free cells was followed in the absence or presence of unlabelled drug. It was found that etretinate enhanced cellular uptake of vindesine in two of the cell lines and this may be responsible for the enhanced toxicity of vindesine in the presence of etretinate. The human melanoma which did not exhibit retinoid stimulated vindesine uptake, appeared to be intrinsically sensitive to the vinca alkaloid. No effect on cellular retinoid uptake by vindesine was recorded in any of the melanomas. The results indicate that the intracellular concentrations combined with the intrinsic sensitivities of each cell line to etretinate and vindesine determines the toxic response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041363      PMCID: PMC1977201          DOI: 10.1038/bjc.1985.203

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Inhibition of the growth and development of a transplantable murine melanoma by vitamin A.

Authors:  E L Felix; B Loyd; M H Cohen
Journal:  Science       Date:  1975-09-12       Impact factor: 47.728

2.  The effect of crocetin on skin papillomas and Rous sarcoma.

Authors:  J L Gainer; D A Wallis; J R Jones
Journal:  Oncology       Date:  1976       Impact factor: 2.935

3.  Correlation of cytotoxicity and mitotic spindle dissolution by vinblastine in mammalian cells.

Authors:  R W Tucker; R J Owellen; S B Harris
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

4.  Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.

Authors:  M H Cohen; P P Carbone
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

5.  Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro.

Authors:  B T Hill; R D Whelan
Journal:  Cancer Treat Rev       Date:  1980-09       Impact factor: 12.111

6.  Studies on the mechanism of induction of embryonal carcinoma cell differentiation by retinoic acid.

Authors:  M I Sherman; K I Matthaei; J Schindler
Journal:  Ann N Y Acad Sci       Date:  1981-02-27       Impact factor: 5.691

Review 7.  Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells.

Authors:  R Lotan
Journal:  Biochim Biophys Acta       Date:  1980-03-12

Review 8.  Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).

Authors:  R W Dyke; R L Nelson
Journal:  Cancer Treat Rev       Date:  1977-06       Impact factor: 12.111

9.  Effect of retinoic acid pretreatment on 12-O-tetradecanoylphorbol-13-acetate-induced cell population kinetics and polyamine biosynthesis in hairless mouse epidermis.

Authors:  E G Astrup; J E Paulsen
Journal:  Carcinogenesis       Date:  1982       Impact factor: 4.944

10.  Inhibition of human melanoma colony formation by retinoids.

Authors:  F L Meyskens; S E Salmon
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

View more
  2 in total

1.  Cytotoxic effects of vitamin A in combination with vincristine, daunorubicin and 6-thioguanine upon cells from lymphoblastic leukemic patients.

Authors:  R Pieters; D R Huismans; A H Loonen; K Hählen; A J Veerman
Journal:  Jpn J Cancer Res       Date:  1991-09

2.  Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.

Authors:  Enchong Zhang; Yijing Chen; Shurui Bao; Xueying Hou; Jing Hu; Oscar Yong Nan Mu; Yongsheng Song; Liping Shan
Journal:  Hum Genomics       Date:  2021-08-12       Impact factor: 4.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.